Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications

被引:76
作者
Duquesnoy, R. J. [1 ]
机构
[1] Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Div Transplantat Pathol, Pittsburgh, PA 15213 USA
来源
TISSUE ANTIGENS | 2011年 / 77卷 / 06期
关键词
acceptable mismatch; eplet; HLAMatchmaker; human leukocyte antigen antibody; human leukocyte antigen (HLA) epitope; MOLECULARLY BASED ALGORITHM; HIGHLY SENSITIZED PATIENTS; CLASS-I EPITOPES; HISTOCOMPATIBILITY DETERMINATION; HLA-DR; THROMBOCYTOPENIC PATIENTS; POSITIVE SELECTION; DEFINED EPLETS; SERUM ANALYSIS; DQ-ALPHA;
D O I
10.1111/j.1399-0039.2011.01646.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Antibodies against allogeneic human leukocyte antigen (HLA) molecules are important impediments to the success of different clinical procedures including transplantation and platelet transfusion. In these settings, characterization of the repertoire of immunogenic epitopes is important for permissible mismatch determination and the identification of acceptable mismatches for sensitized patients. HLAMatchmaker is a computer algorithm that considers small configurations of polymorphic residues referred to as eplets as essential components of HLA epitopes. This review critically elaborates the concepts underlying the HLAMatchmaker and describes the usefulness of HLAMatchmaker in the clinical setting. Recent developments have increased our understanding of structural basis of HLA antigenicity (i.e. reactivity with specific antibody) and immunogenicity (i.e. its ability to induce an antibody response).
引用
收藏
页码:525 / 534
页数:10
相关论文
共 68 条
[1]   Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches [J].
Adeyi, OA ;
Girnita, AL ;
Howe, J ;
Marrari, M ;
Awadalla, Y ;
Askar, M ;
Martell, J ;
Zeevi, A ;
Shapiro, R ;
Nalesnik, M ;
Randhawa, P ;
Demetris, AJ ;
Duquesnoy, RJ .
TRANSPLANT IMMUNOLOGY, 2005, 14 (01) :53-62
[2]  
[Anonymous], TRANSPL INT
[3]  
[Anonymous], TRANSPLANT IN PRESS
[4]   Antibodies against HLA-DQ α-chain and their role in organ transplantation [J].
Barabanova, Yelena ;
Ramon, Daniel S. ;
Tambur, Anat R. .
HUMAN IMMUNOLOGY, 2009, 70 (06) :410-412
[5]   The practicability of HLA matching [J].
Boehringer, D. ;
Reinhard, T. .
OPHTHALMOLOGE, 2007, 104 (03) :219-221
[6]  
Böhringer D, 2010, MOL VIS, V16, P2362
[7]   Anatomy of hot spots in protein interfaces [J].
Bogan, AA ;
Thorn, KS .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 280 (01) :1-9
[8]   Beneficial effect of matching at the HLA-A and -B amino-acid triplet level on rejection-free clear graft survival in penetrating keratoplasy [J].
Böhringer, D ;
Reinhard, T ;
Duquesnoy, RJ ;
Böhringer, S ;
Enczmann, J ;
Lange, P ;
Claas, F ;
Sundmacher, R .
TRANSPLANTATION, 2004, 77 (03) :417-421
[9]  
Brecher ME., 2005, Technical Manual, V15th
[10]   Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions [J].
Brooks, Erin G. ;
MacPherson, Bruce R. ;
Fung, Mark K. .
TRANSFUSION, 2008, 48 (10) :2159-2166